kabutan

Carna Biosciences, First Half Net Income Loss Narrows, Apr-Jun Net Income Loss Narrows

Wed Aug 6, 2025 4:00 pm JST Earnings

4572 Carna Biosciences, Inc. 【J-GAAP】

Earnings Report

Carna Biosciences, Inc. <4572> [TSE Growth] announced its financial results after the market closed on August 6th (16:00). The consolidated net loss for the cumulative second quarter of the fiscal year ending December 2025 (January to June) was a reduced loss of 1.05 billion yen (compared to a loss of 1.09 billion yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net loss for the July to December period (second half) is expected to nearly flat at loss of 1.09 billion yen (compared to a loss of 1.08 billion yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the consolidated net loss improved to a deficit of 0.55 billion yen (compared to a loss of 0.69 billion yen in the same period last year). However, the operating profit/loss margin drastically worsened from -503.0% in the same period last year to -513.9%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 500 -863 -868 -885 -53.8 ー Aug 7, 2023 J-GAAP
Jan - Jun, 2024 315 -1,095 -1,087 -1,094 -63.3 ー Aug 7, 2024 J-GAAP
Jan - Jun, 2025 251 -1,052 -1,055 -1,056 -55.3 ー Aug 6, 2025 J-GAAP
YoY -20.3% +3.9% +2.9% +3.5% +12.6%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 10, 2025 J-GAAP
Jan - Jun, 2025 Results 251 -1,052 -1,055 -1,056 -55.3 0 Aug 6, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 321 -981 -993 -1,084 -60.5 0 Feb 10, 2025 J-GAAP
Jul - Dec, 2025 Guidance 471 -1,081 -1,082 -1,091 -57.0 0 Aug 6, 2025 J-GAAP
YoY +46.7% -10.2% -9.0% -0.6% +5.8%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,625 -1,116 -1,126 -1,152 -68.6 0 Feb 9, 2024 J-GAAP
Dec, 2024 636 -2,076 -2,080 -2,178 -121.6 0 Feb 10, 2025 J-GAAP
Dec, 2025 Guidance 722 -2,133 -2,137 -2,147 -112.2 0 Feb 10, 2025 J-GAAP
YoY +13.5% -2.7% -2.7% +1.4% +7.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 135 -679 -693 -696 -40.2 -503.0 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 172 -483 -492 -494 -28.2 -280.8 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 149 -498 -501 -590 -33.0 -334.2 Feb 10, 2025 J-GAAP
Jan - Mar, 2025 143 -497 -498 -499 -26.1 -347.6 May 9, 2025 J-GAAP
Apr - Jun, 2025 108 -555 -557 -557 -29.2 -513.9 Aug 6, 2025 J-GAAP
YoY -20.0% +18.3% +19.6% +20.0% +27.5%

Related Articles